Showing results (321-330 of 781) with videos related to
Sort By:
Pageof 79
Expert Opinion on Pharmacotherapy|November 28, 2017
Lenalidomide in combination or alone as maintenance therapy following autologous stem cell transplant in patients with multiple myeloma: a review of options for and againstPaul G Richardson, Sarah A Holstein, Robert L Schlossman, et al.Leukemia|April 3, 2020
Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathwaysTeru Hideshima, Daisuke Ogiya, Jiye Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|June 7, 2005
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myelomaTeru Hideshima, James E Bradner, Jason Wong, et al.Blood|April 2, 2011
A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cellsAjita V Singh, Madhavi Bandi, Noopur Raje, et al.Blood Cancer Journal|December 10, 2023
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myelomaDebasmita Dutta, Jiye Liu, Kenneth Wen, et al.British Journal of Haematology|March 25, 2010
Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine modelAjita V Singh, Michael A Palladino, George Kenneth Lloyd, et al.Antioxidants & Redox Signaling|February 17, 2024
DAMPening Tumor Immune Escape: The Role of Endoplasmic Reticulum Chaperones in Immunogenic ChemotherapySelma Cifric, Marcello Turi, Pietro Folino, et al.Nature Communications|August 25, 2019
Genomic landscape and chronological reconstruction of driver events in multiple myelomaFrancesco Maura, Niccoló Bolli, Nicos Angelopoulos, et al.British Journal of Haematology|January 12, 2011
Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancersPaul G Richardson, Constantine S Mitsiades, Jacob P Laubach, et al.Journal of Leukemia (Los Angeles, Calif.)|September 27, 2016
Lenalidomide Polarizes Th1-specific Anti-tumor Immune Response and Expands XBP1 Antigen-Specific Central Memory CD3+CD8+ T cells against Various Solid TumorsJooeun Bae, Derin B Keskin, Kristen Cowens, et al.Pageof 79